ANIX: KUMAR AMIT discloses a purchase

By AlphaYouPublished Sep 28, 2026Form 4

Stocks in this disclosure

Reported activity

KUMAR AMIT

Reporting filer

KUMAR AMIT reported Purchase in Anixa Biosciences Inc: 7000 units of Common Stock, dated 2026-09-24. The full Form 4 contains 1 transaction entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	KUMAR AMIT	2026-09-24	P	Purchase	7000	2.78	672,000	4 days	Filed terms security Title: Common Stock transaction Date: 2026-09-24 deemed Execution Date: transaction Form Type: 4 transaction Code: P equity Swap Involved: 0 transaction Timeliness: transaction Shares: 7000 transaction Price Per Share: 2.78 transaction Acquired Disposed Code: A shares Owned Following Transaction: 672000 direct Or Indirect Ownership: D

Owner: KUMAR AMIT
Date: 2026-09-24
Code: P
Action: Purchase
Quantity: 7000
Price: 2.78
Following holdings: 672,000
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-24
deemed Execution Date:
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 7000
transaction Price Per Share: 2.78
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 672000
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
KUMAR AMIT: Chief Executive Officer, Director.

Prepared automatically from public filing data. Report a correction.